PURPOSE: Improvements in survival after septic shock will most likely rely on our capacity to manage individualized therapies based on the measurement of rapidly accessible biomarkers. As the early phase of septic shock is dominated by severe alterations of the cardiovascular system, the predictive value for mortality of pro-vasopressin (pro-AVP) and pro-adrenomedullin (pro-ADM), two vasoactive pro-hormones, was assessed. METHODS: In 99 consecutive patients, pro-hormone concentrations were measured (immunoluminometric assay) three times within the first week after the onset of septic shock. RESULTS: Pro-AVP and pro-ADM concentrations were significantly increased in non-survivors in comparison with survivors and were significantly associated with mortality after both univariate and multivariate analysis. Importantly, when assessed as a pair, pro-ADM and pro-AVP were even more informative. CONCLUSIONS: Both Pro-ADM and pro-AVP appear to be good biomarkers for the prediction of 28-day mortality after septic shock. However, their association in a single variable tends to improve their predictive capacity.
PURPOSE: Improvements in survival after septic shock will most likely rely on our capacity to manage individualized therapies based on the measurement of rapidly accessible biomarkers. As the early phase of septic shock is dominated by severe alterations of the cardiovascular system, the predictive value for mortality of pro-vasopressin (pro-AVP) and pro-adrenomedullin (pro-ADM), two vasoactive pro-hormones, was assessed. METHODS: In 99 consecutive patients, pro-hormone concentrations were measured (immunoluminometric assay) three times within the first week after the onset of septic shock. RESULTS: Pro-AVP and pro-ADM concentrations were significantly increased in non-survivors in comparison with survivors and were significantly associated with mortality after both univariate and multivariate analysis. Importantly, when assessed as a pair, pro-ADM and pro-AVP were even more informative. CONCLUSIONS: Both Pro-ADM and pro-AVP appear to be good biomarkers for the prediction of 28-day mortality after septic shock. However, their association in a single variable tends to improve their predictive capacity.
Authors: Sohail Q Khan; Onkar Dhillon; Joachim Struck; Paulene Quinn; Nils G Morgenthaler; Ian B Squire; Joan E Davies; Andreas Bergmann; Leong L Ng Journal: Am Heart J Date: 2007-10 Impact factor: 4.749
Authors: Sohail Q Khan; Onkar S Dhillon; Russell J O'Brien; Joachim Struck; Paulene A Quinn; Nils G Morgenthaler; Iain B Squire; Joan E Davies; Andreas Bergmann; Leong L Ng Journal: Circulation Date: 2007-04-09 Impact factor: 29.690
Authors: Sohail Q Khan; Russell J O'Brien; Joachim Struck; Paulene Quinn; Nils Morgenthaler; Iain Squire; Joan Davies; Andreas Bergmann; Leong L Ng Journal: J Am Coll Cardiol Date: 2007-03-26 Impact factor: 24.094
Authors: Mirjam Christ-Crain; Nils G Morgenthaler; Joachim Struck; Stephan Harbarth; Andreas Bergmann; Beat Müller Journal: Crit Care Date: 2005-11-15 Impact factor: 9.097
Authors: Francisco Valenzuela-Sánchez; Blanca Valenzuela-Méndez; Juan Francisco Rodríguez-Gutiérrez; Ángel Estella-García; María Ángela González-García Journal: Ann Transl Med Date: 2016-09
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2010-01-08 Impact factor: 17.440
Authors: B Suberviola; A Castellanos-Ortega; A Ruiz Ruiz; M Lopez-Hoyos; M Santibañez Journal: Intensive Care Med Date: 2013-08-16 Impact factor: 17.440
Authors: Paris Avgoustou; Ameera B A Jailani; Jean-Olivier Zirimwabagabo; Matthew J Tozer; Karl R Gibson; Paul A Glossop; James E J Mills; Roderick A Porter; Paul Blaney; Peter J Bungay; Ning Wang; Alice P Shaw; Kamilla J A Bigos; Joseph L Holmes; Jessica I Warrington; Timothy M Skerry; Joseph P A Harrity; Gareth O Richards Journal: ACS Pharmacol Transl Sci Date: 2020-06-25